ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/01 | 1,997 | 2,018 | 1,992 | 2,015 | +18 | +0.9% | 105,500 |
2021/02/26 | 2,025 | 2,031 | 1,997 | 1,997 | -25 | -1.2% | 159,800 |
2021/02/25 | 2,048 | 2,053 | 2,022 | 2,022 | -11 | -0.5% | 72,000 |
2021/02/24 | 2,024 | 2,043 | 2,008 | 2,033 | +9 | +0.4% | 80,900 |
2021/02/22 | 2,012 | 2,043 | 2,012 | 2,024 | +2 | +0.1% | 46,600 |
2021/02/19 | 2,018 | 2,031 | 2,010 | 2,022 | -5 | -0.2% | 59,900 |
2021/02/18 | 2,027 | 2,036 | 2,016 | 2,027 | -13 | -0.6% | 46,200 |
2021/02/17 | 2,040 | 2,052 | 2,028 | 2,040 | -14 | -0.7% | 32,300 |
2021/02/16 | 2,059 | 2,059 | 2,037 | 2,054 | -7 | -0.3% | 29,400 |
2021/02/15 | 2,081 | 2,081 | 2,043 | 2,061 | -8 | -0.4% | 61,800 |
2021/02/12 | 2,100 | 2,101 | 2,062 | 2,069 | -26 | -1.2% | 42,200 |
2021/02/10 | 2,089 | 2,117 | 2,086 | 2,095 | +9 | +0.4% | 45,200 |
2021/02/09 | 2,122 | 2,163 | 2,082 | 2,086 | -79 | -3.6% | 114,400 |
2021/02/08 | 2,053 | 2,175 | 2,053 | 2,165 | +156 | +7.8% | 191,500 |
2021/02/05 | 1,998 | 2,022 | 1,987 | 2,009 | +17 | +0.9% | 71,100 |
2021/02/04 | 1,996 | 2,008 | 1,991 | 1,992 | -26 | -1.3% | 33,000 |
2021/02/03 | 2,014 | 2,024 | 2,010 | 2,018 | +18 | +0.9% | 40,500 |
2021/02/02 | 1,990 | 2,020 | 1,985 | 2,000 | +7 | +0.4% | 41,800 |
2021/02/01 | 1,991 | 2,009 | 1,991 | 1,993 | +2 | +0.1% | 43,400 |
2021/01/29 | 2,015 | 2,045 | 1,991 | 1,991 | -31 | -1.5% | 65,200 |
2021/01/28 | 1,973 | 2,034 | 1,968 | 2,022 | +47 | +2.4% | 122,000 |
2021/01/27 | 1,948 | 1,980 | 1,945 | 1,975 | +30 | +1.5% | 85,600 |
2021/01/26 | 1,935 | 1,950 | 1,933 | 1,945 | +19 | +1% | 68,100 |
2021/01/25 | 1,919 | 1,928 | 1,913 | 1,926 | +19 | +1% | 29,300 |
2021/01/22 | 1,918 | 1,921 | 1,907 | 1,907 | -21 | -1.1% | 71,800 |
2021/01/21 | 1,915 | 1,938 | 1,915 | 1,928 | +12 | +0.6% | 77,000 |
2021/01/20 | 1,906 | 1,919 | 1,899 | 1,916 | +10 | +0.5% | 53,100 |
2021/01/19 | 1,918 | 1,918 | 1,902 | 1,906 | -5 | -0.3% | 76,200 |
2021/01/18 | 1,906 | 1,916 | 1,902 | 1,911 | +5 | +0.3% | 45,200 |
2021/01/15 | 1,922 | 1,922 | 1,906 | 1,906 | -20 | -1% | 59,900 |
2021/01/14 | 1,915 | 1,927 | 1,910 | 1,926 | +11 | +0.6% | 82,800 |
2021/01/13 | 1,920 | 1,920 | 1,906 | 1,915 | -20 | -1% | 92,500 |
2021/01/12 | 1,920 | 1,949 | 1,912 | 1,935 | +16 | +0.8% | 75,300 |
2021/01/08 | 1,917 | 1,928 | 1,907 | 1,919 | +2 | +0.1% | 78,200 |
2021/01/07 | 1,918 | 1,923 | 1,908 | 1,917 | +17 | +0.9% | 70,800 |
2021/01/06 | 1,903 | 1,913 | 1,896 | 1,900 | -8 | -0.4% | 89,400 |
2021/01/05 | 1,898 | 1,914 | 1,889 | 1,908 | +10 | +0.5% | 92,700 |
2021/01/04 | 1,891 | 1,906 | 1,870 | 1,898 | -3 | -0.2% | 66,400 |
2020/12/30 | 1,918 | 1,918 | 1,896 | 1,901 | -27 | -1.4% | 38,300 |
2020/12/29 | 1,918 | 1,928 | 1,903 | 1,928 | +21 | +1.1% | 48,000 |
2020/12/28 | 1,915 | 1,927 | 1,898 | 1,907 | -4 | -0.2% | 53,000 |
2020/12/25 | 1,918 | 1,918 | 1,903 | 1,911 | +7 | +0.4% | 58,800 |
2020/12/24 | 1,906 | 1,910 | 1,892 | 1,904 | +3 | +0.2% | 68,700 |
2020/12/23 | 1,905 | 1,911 | 1,894 | 1,901 | +6 | +0.3% | 91,200 |
2020/12/22 | 1,911 | 1,911 | 1,894 | 1,895 | -16 | -0.8% | 57,300 |
2020/12/21 | 1,910 | 1,917 | 1,894 | 1,911 | -3 | -0.2% | 34,400 |
2020/12/18 | 1,901 | 1,914 | 1,895 | 1,914 | +13 | +0.7% | 54,200 |
2020/12/17 | 1,904 | 1,912 | 1,890 | 1,901 | +2 | +0.1% | 66,100 |
2020/12/16 | 1,917 | 1,918 | 1,899 | 1,899 | -14 | -0.7% | 72,500 |
2020/12/15 | 1,913 | 1,933 | 1,910 | 1,913 | -18 | -0.9% | 39,700 |
1101~
1150
件表示中 / 3770件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 204,700円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 265,700円 | +21.7% | +999.9% | 0.00% | 12.24倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 311,500円 | +5.1% | -7.0% | 2.57% | 20.45倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 241,900円 | +4.1% | -3.1% | 2.40% | 21.01倍 | 1.83倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 152,500円 | -2.4% | -52.3% | 3.74% | 18.25倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム